These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Early hospital experience with fluphenazine decanoate. Small JG; Kellams J Dis Nerv Syst; 1974 Oct; 35(10):453-6. PubMed ID: 17894058 [TBL] [Abstract][Full Text] [Related]
3. Late-Onset Rhabdomyolysis Associated With an Intramuscular Injection of Fluphenazine Decanoate. Umino M; Kobayashi R; Nisijima K; Suda S Prim Care Companion CNS Disord; 2017 Sep; 19(5):. PubMed ID: 28972705 [No Abstract] [Full Text] [Related]
5. Adverse extrapyramidal effects in four horse given fluphenazine decanoate. Baird JD; Arroyo LG; Vengust M; McGurrin MK; Rodriguez-Palacios A; Kenney DG; Aravagiri M; Maylin GA J Am Vet Med Assoc; 2006 Jul; 229(1):104-10. PubMed ID: 16817724 [TBL] [Abstract][Full Text] [Related]
8. Catatonia associated with phenylpropanolamine overdose and fluphenazine treatment: case report. Castellani S J Clin Psychiatry; 1985 Jul; 46(7):288-9. PubMed ID: 4008454 [TBL] [Abstract][Full Text] [Related]
9. [Clinical and biological effects of fluphénazine décanoate. 35 cases]. Borenstein P; Dumaine A; Cujo P Ann Med Psychol (Paris); 1970 Jul; 2(2):267-73. PubMed ID: 5475413 [No Abstract] [Full Text] [Related]
10. Fluphenazine-induced extrapyramidal side effects in a horse. Brashier M Vet Clin North Am Equine Pract; 2006 Apr; 22(1):e37-45. PubMed ID: 16627093 [No Abstract] [Full Text] [Related]
11. Suggestions to improve conversion of fluphenazine dosage forms. Raleigh F Am J Health Syst Pharm; 1996 Jul; 53(14):1727, 1732. PubMed ID: 8827245 [No Abstract] [Full Text] [Related]
12. Discrepancies on prescribing antipsychotics. Dollfus S; Van Os J; Petit M Br J Psychiatry; 1995 Feb; 166(2):263-4. PubMed ID: 7728377 [No Abstract] [Full Text] [Related]
13. Significant greater loss of medication from the injection site when fluphenazine (Prolixin) decanoate was injected intramuscularly as contrasted with subcutaneously. Gelenberg AJ J Clin Psychiatry; 1987 Oct; 48(10):425. PubMed ID: 3667545 [No Abstract] [Full Text] [Related]
14. Inadvertent administration of intravenous ziprasidone leading to bradycardia and QT interval prolongation. Bentley ML; Biscardi FH; Butcher C; Levitov A Ann Pharmacother; 2008 Jun; 42(6):902-3. PubMed ID: 18477728 [No Abstract] [Full Text] [Related]
15. Rhinorrhea related to antipsychotic drug therapy. Orfan NA; Kolski GB J Allergy Clin Immunol; 1993 Feb; 91(2):681-2. PubMed ID: 8094723 [No Abstract] [Full Text] [Related]
16. Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables. Stanković Z; Britvić D; Vuković O; Ille T Psychiatr Danub; 2008 Mar; 20(1):42-52. PubMed ID: 18376330 [TBL] [Abstract][Full Text] [Related]
17. Chronic treatment with fluphenazine alters parameters of oxidative stress in liver and kidney of rats. Corte CL; Fachinetto R; Puntel R; Wagner C; Nogueira CW; Soares FA; Rocha JB Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):51-7. PubMed ID: 19486337 [TBL] [Abstract][Full Text] [Related]
18. [Status epilepticus as a complication of fluphenazine treatment]. Leksowski W Psychiatr Pol; 1983; 17(5-6):445-7. PubMed ID: 6669666 [No Abstract] [Full Text] [Related]
19. [Odd side effects of an analgesic]. Mäkila H Duodecim; 1999; 115(12):1318,1321. PubMed ID: 11917890 [No Abstract] [Full Text] [Related]